Heron Therapeutics HRTX Reports Weak Q1 2026 Cost Pressures Weigh on Margins Chemours CC Delivers Q1 2026 Beat EPS 005 vs 005 Expected Saratoga SAV Holds 2502 Direction Awaited 20260520 Kevin Warsh Poised to Enter Fed Amid Internal Divisions Over Interest Rate Policy CCB Q1 2026 Earnings EPS Misses Estimates Stock Declines Lamar Advertising Q1 2026 Earnings EPS Beat Drives Modest Stock Gain GrafTech Q1 2026 Earnings EPS Miss Exceeds 40 Yet Stock Rebounds Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates NovaBridge Biosciences NBP Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 508 SCM Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Declines